RTI Surgical Receives Regulatory Clearances for nanOss Bioactive in Australia, Europe

RTI Surgical received regulatory clearance from the Australian Therapeutic Goods Administration for nanOss® Bioactive bone void filler in Australia, as well as CE Mark for nanOss Bioactive Loaded and nanOss Bioactive 3D in Europe. The products will be distributed by LifeHealthcare in Australia and independent distributors in the EU.


document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us